FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
JCR Pharmaceuticals Co., Ltd. Stock AnalysisComprehensive stock analysis for JCR Pharmaceuticals Co., Ltd. (JCRRF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisJCRRF
JCRRF
JCR Pharmaceuticals Co., Ltd.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
JCRRF
Home🔹Stocks🔹JCR Pharmaceuticals Co., Ltd.

JCR Pharmaceuticals Co., Ltd.

JCRRF•OTC

JCR Pharmaceuticals Co., Ltd.

JCRRF•OTC
Market cap
$508.67M
Sentiment

Your view on JCRRF

Mkt Cap
$508.67M
Sentiment
Your view
JCRRF
JCR Pharmaceuticals Co., Ltd.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
JCRRF
Company Overview

Overview

What the company does, where it operates, and who runs it.

About JCR Pharmaceuticals Co., Ltd.

Industry
Drug Manufacturers - General
Sector
Healthcare
CEO
Shin Ashida
Headquarters
3-19 Kasuga-cho, Ashiya, JP
Industry
Drug Manufacturers - General
Sector
Healthcare
CEO
Shin Ashida
Headquarters
3-19 Kasuga-cho, Ashiya, JP
Description

JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company also develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells medical devices and laboratory instruments. JCR Pharmaceuticals Co., Ltd. was incorporated in 1975 and is headquartered in Ashiya, Japan.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News